Related Experiment Video
Updated: Jan 9, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Three-Decade Analysis of Inflammatory Bowel Disease in Türkiye: A Multicenter Study (1993-2024)
Muhammed Bahaddin Durak1, Yasir Furkan Cagin2, Ayhan Balkan3
1Department of Gastroenterology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Inflammatory bowel diseases (IBD) are rising in Türkiye, with Crohn's Disease increasing relative to ulcerative colitis. While biologic therapy use and Crohn's Disease rates have climbed, surgical interventions for IBD have declined over three decades.
Area of Science:
- Gastroenterology
- Epidemiology
- Internal Medicine
Background:
- Inflammatory bowel diseases (IBD) present a growing global health challenge.
- Understanding regional IBD trends, particularly between Europe and Asia, is crucial.
- This study examines the evolving patterns of IBD in Türkiye over the past 30 years.
Purpose of the Study:
- To investigate the epidemiological trends and clinical characteristics of IBD in Türkiye.
- To analyze changes in IBD prevalence, patient demographics, and treatment modalities over three decades.
- To compare IBD patterns in Türkiye with those observed in European and Asian regions.
Main Methods:
- Retrospective analysis of 4308 IBD patients across 14 centers in Türkiye.
- Data collection spanned from June 1993 to March 2024.
- Inclusion criteria covered ulcerative colitis and Crohn's Disease diagnoses.
Main Results:
- Over 30 years, IBD prevalence increased, with a decreasing ulcerative colitis to Crohn's Disease ratio.
- The median age of IBD onset was 34.43 years, younger in Crohn's Disease (32.72) than ulcerative colitis (35.52).
- Biologic therapy use rose to 36.6%, while major abdominal surgeries decreased, with 24.3% undergoing surgery for Crohn's Disease and 3.5% for ulcerative colitis.
Conclusions:
- IBD frequency and characteristics in Türkiye position it between European and Asian epidemiological profiles.
- Increasing prevalence of Crohn's Disease and rising use of biologic therapies mark recent trends.
- A significant decline in the rate of major abdominal surgeries for IBD has been observed over the study period.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF